Global Prevention and Treatment of Prostate Cancer Market should reach nearly $65.1 billion in 2021 | Research Cosmos
Researchcosmos.com published “prostate cancer products” from its database. The report provides detailed analysis of the market sizing and future growth
(EMAILWIRE.COM, March 09, 2018 ) The global market for prostate cancer products reached nearly $47.2 billion in 2016 and should reach nearly $65.1 billion in 2021, with a compound annual growth rate (CAGR) of 6.6%.
Explore More Information about report @ https://www.researchcosmos.com/reports/global-prevention-and-treatment-of-prostate-cancer-market-analysis-with-forecasts-to-2022-growth-o/1830468673
Report Scope:
The scope of this study is testing, screening technology and also therapeutics markets for prostate cancer. The report also includes the regulatory environment, current technologies, new technologies, prostate cancer incidence, market projections and market share, along with latest trends and new developments.
Screening for diagnosis, therapy via drug, surgery or radiation is measured and broken down by PSA testing, digital rectal exam (DRE), prostate biopsy, hormone therapy, chemotherapy, immunotherapy, external beam radiation therapy (EBRT), prostatectomy and brachytherapy.
Request free sample @ https://www.researchcosmos.com/request/1830468673
Report Includes:
- An overview of the market for the prevention and treatment of prostate cancer, with coverage of the mechanisms of disease development, detection and diagnosis, and anticancer agents
- Analyses of global market trends, with data from 2012, 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Discussion of risk factors, natural history, epidemiology, and the genetics of prostate cancer
- Examinations of prostate-specific antigen (PSA) screening, including the causes of PSA changes, PSA thresholds, and controversies over the screening
- Coverage of emerging therapies, including combination therapy, therapeutic vaccines, inhibitors of kinase signaling pathways, proteasome inhibitors, angiogenesis inhibitors, and immunotherapeutic agents
- Evaluation of prostate cancer treatment products by geography, race, and category
- Breakdown of the industry structure, including market shares, trends in price and price performance, and factors influencing demand
- Comprehensive company profiles of major players in the field.
Check for Discount @ https://www.researchcosmos.com/discount/1830468673
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Explore More Information about report @ https://www.researchcosmos.com/reports/global-prevention-and-treatment-of-prostate-cancer-market-analysis-with-forecasts-to-2022-growth-o/1830468673
Report Scope:
The scope of this study is testing, screening technology and also therapeutics markets for prostate cancer. The report also includes the regulatory environment, current technologies, new technologies, prostate cancer incidence, market projections and market share, along with latest trends and new developments.
Screening for diagnosis, therapy via drug, surgery or radiation is measured and broken down by PSA testing, digital rectal exam (DRE), prostate biopsy, hormone therapy, chemotherapy, immunotherapy, external beam radiation therapy (EBRT), prostatectomy and brachytherapy.
Request free sample @ https://www.researchcosmos.com/request/1830468673
Report Includes:
- An overview of the market for the prevention and treatment of prostate cancer, with coverage of the mechanisms of disease development, detection and diagnosis, and anticancer agents
- Analyses of global market trends, with data from 2012, 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Discussion of risk factors, natural history, epidemiology, and the genetics of prostate cancer
- Examinations of prostate-specific antigen (PSA) screening, including the causes of PSA changes, PSA thresholds, and controversies over the screening
- Coverage of emerging therapies, including combination therapy, therapeutic vaccines, inhibitors of kinase signaling pathways, proteasome inhibitors, angiogenesis inhibitors, and immunotherapeutic agents
- Evaluation of prostate cancer treatment products by geography, race, and category
- Breakdown of the industry structure, including market shares, trends in price and price performance, and factors influencing demand
- Comprehensive company profiles of major players in the field.
Check for Discount @ https://www.researchcosmos.com/discount/1830468673
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Information:
Research Cosmos
Dani Rodriguez
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research Cosmos
Dani Rodriguez
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results